Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Nov;96(11):1965-70.
doi: 10.2105/AJPH.2005.067926. Epub 2006 Oct 3.

Genes, race, and population: avoiding a collision of categories

Affiliations

Genes, race, and population: avoiding a collision of categories

Jonathan Kahn. Am J Public Health. 2006 Nov.

Abstract

A wide array of federal mandates have a profound impact on the use of racial and ethnic categories in biomedical research, clinical practice, product development, and health policy. Current discussions over the appropriate use of racial and ethnic categories in biomedical contexts have largely focused on the practices of individual researchers. By contrast, our discussion focuses on relations between the daily practices of biomedical professionals and federal regulatory mandates. It draws upon the legal doctrine of equal protection to move beyond such debates and to propose guidelines to address the structural forces imposed by federal regulations that mandate how data about race and ethnicity are used in biomedical research. It offers a framework to manage the tension involved in using existing federally mandated categories of race and ethnicity alongside new scientific findings about human genetic variation.

PubMed Disclaimer

References

    1. Food and Drug Administration, “FDA Approves BiDil Heart Failure Drug for Black Patients,” FDA News, June 23, 2005. Available at: http://www.fda.gov/bbs/topics/NEWS/2005/NEW01190.html. Accessed July 5, 2005.
    1. Kahn Jonathan, “How a Drug Becomes “Ethnic”: Law, Commerce, and the Production of Racial Categories in Medicine, Yale J Health Policy Law Ethics 4 (2004): 1–46. - PubMed
    1. Kahn Jonathan, “Ethnic Drugs,” Hastings Cent Report 35, Jan–Feb (2005): 1 p following 48. For a discussion of the trail design and data supporting the BiDil application, see Anne L. Taylor, et al., “Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure,” N Engl J Med 351 (2004): 2049–2057. - PubMed
    1. Cohn J, and Carson P. 2002. Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate. US Patent 6,465,463, issued October 15, 2002.
    1. Institute of Medicine, Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care (Washington, DC: National Academies Press, 2002). - PubMed

Publication types

MeSH terms

LinkOut - more resources